The UK’s biggest healthcare agency, Medical Action Communications
(MAC), has merged with the world’s largest contract pharmaceutical
organisation in a multi-million pound deal.
MAC, ranked number one in the PR Week healthcare league tables for the
last three years, is to become a service group of US-based Quintiles
The merger deal culminated in a share-for-share exchange late last
Quintiles acquired all of MAC’s stock for around 566,000 shares, worth
around pounds 22 million at the time of the transaction.
This means that founder and managing director of MAC Stephen Bullock
shares the bumper package with his four co-directors Mark Radice, Jane
White, Brian Green and Tricia Kabler-Sharland. However it is not known
what level of debt the partners carried in their individual stakes.
All five will become shareholders of Quintiles.
Bullock was keen to emphasise that MAC will remain autonomous. It will
operate as one of four Quintile service groups - product development arm
Quintiles CRO, healthcare policy consultancy The Lewin Group, and
Innovex, the sales and marketing company.
’For our customers it’s business as usual,’ he said. ’We will continue
to provide our existing clients with the same services but they have the
opportunity to use Quintiles’ other services.
MAC’s major clients include SmithKline Beecham and Pfizer
As MAC’s CEO, Bullock will report to Quintiles’ president and CEO, Santo
The MAC deal means that Quintiles will be able to offer a full range of
contract services, including research and development, sales and
marketing, and PR and tactical implementation, to its pharmaceutical and
Based in North Carolina, Quintiles has over 8,000 employees located in
63 offices in 22 countries.